SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,300,201 | -38.5% | 1,239,251 | -17.6% | 0.00% | -33.3% |
Q2 2023 | $6,991,712 | +169642.9% | 1,503,594 | +68.6% | 0.00% | +50.0% |
Q1 2023 | $4,119 | -62.8% | 891,616 | -34.9% | 0.00% | -66.7% |
Q4 2022 | $11,062 | -99.9% | 1,369,021 | -46.0% | 0.01% | -25.0% |
Q3 2022 | $14,081,000 | +12.1% | 2,537,070 | +5.2% | 0.01% | +14.3% |
Q2 2022 | $12,563,000 | +346.8% | 2,411,392 | +604.8% | 0.01% | +600.0% |
Q1 2022 | $2,812,000 | +29.8% | 342,131 | +134.9% | 0.00% | 0.0% |
Q4 2021 | $2,167,000 | -46.5% | 145,635 | -32.1% | 0.00% | -50.0% |
Q3 2021 | $4,053,000 | -54.4% | 214,583 | -55.1% | 0.00% | -60.0% |
Q2 2021 | $8,888,000 | -32.9% | 478,120 | -17.8% | 0.01% | -44.4% |
Q1 2021 | $13,242,000 | +126.4% | 581,799 | +115.9% | 0.01% | +125.0% |
Q4 2020 | $5,850,000 | +82.4% | 269,484 | -15.6% | 0.00% | 0.0% |
Q3 2020 | $3,208,000 | +124.5% | 319,214 | +73.3% | 0.00% | +100.0% |
Q2 2020 | $1,429,000 | +429.3% | 184,147 | +595.6% | 0.00% | +100.0% |
Q1 2020 | $270,000 | -26.2% | 26,475 | -20.5% | 0.00% | – |
Q4 2019 | $366,000 | +55.1% | 33,303 | +27.9% | 0.00% | – |
Q3 2019 | $236,000 | +11.3% | 26,037 | +39.9% | 0.00% | – |
Q2 2019 | $212,000 | -50.6% | 18,605 | -50.6% | 0.00% | -100.0% |
Q1 2019 | $429,000 | -62.7% | 37,660 | -50.9% | 0.00% | 0.0% |
Q3 2018 | $1,150,000 | – | 76,662 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |